.
..eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention..
every single pronouncement, on any subject, issued via the medical cartel�s ministry of truth would fall on disbelieving ears, and only increase general outrage..